Publication:
IS SECOND LINE SYSTEMIC CHEMOTHERAPY BENEFICIAL IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)? : A MULTICENTER DATA EVALUATION OF ANATOLIAN SOCIETY OF MEDICAL ONCOLOGY (ASMO)

Thumbnail Image

Date

2013

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Research Projects

Organizational Units

Journal Issue

Abstract

Description

Keywords

prognostic factors, survival, non-small cell lung cancer, second line treatment

Citation

URI

https://hdl.handle.net/11424/221563

Collections

Araştırma Çıktıları

Endorsement

Review

Supplemented By

Referenced By